The Compound and Friends cover image

Everybody's Wrong

The Compound and Friends

00:00

Contrarian Insights on Biotech and Tech Stocks

This chapter explores the beleaguered state of the healthcare and biotech sectors amidst a contrasting performance from other market sectors. The discussion highlights the concept of contrarian investing in biotech, particularly in the context of historical underperformance and shifting market dynamics. Additionally, the chapter examines the volatility of major tech stocks, including Tesla and Apple, alongside crucial technical indicators that could impact investor strategies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app